However, in rats with lithium-induced nephrogenic diabetes insipidus (Li-NDI), activation of MR markedly increased urine volume, whereas the blockade of MR with spironolactone decreased urine production. The gene discussed is NR3C2; the disease is nephrogenic diabetes insipidus.